Page last updated: 2024-08-25

acamprosate and Chemical Dependence

acamprosate has been researched along with Chemical Dependence in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.35)18.7374
1990's4 (17.39)18.2507
2000's8 (34.78)29.6817
2010's7 (30.43)24.3611
2020's3 (13.04)2.80

Authors

AuthorsStudies
Hulme, J; Sheikh, H; Wiercigroch, D1
Kenny, PJ; O'Brien, CP; Pierce, RC; Swinford-Jackson, SE; Unterwald, EM; Vanderschuren, LJMJ1
English, K; Gu, LY; Madden, EF; Mensah, NA; Qeadan, F; Venner, KL1
Hughes, JR; Klemperer, EM; Naud, S1
Friedmann, PD; Park, TW1
Creedon, TB; Hodgkin, D; Horgan, CM; Matteucci, AM; Reif, S; Stewart, MT1
Chand, PK; Thirthalli, J1
Capone, C; Kahler, CW; O'Malley, SS; Swift, RM1
Alam, DA; Martorana, A1
Abraham, AJ; Knudsen, HK; Roman, PM1
Clark, DB1
O'Brien, CP1
Beilby, JJ; Doran, CM; Duszynski, KM; Mattick, RP1
Coyle, JT1
Brunette, MF; Drake, RE; Green, AI; Noordsy, DL1
Brunette, MF; Green, AI; Noordsy, DL; O'Keefe, C1
Berglund, M; Gorelick, D; Hesselbrock, V; Johnson, BA; Kranzler, HR; Möller, HJ; Soyka, M1
Schuckit, MA1
Wickelgren, I1
Allen, JP; Litten, RZ1
Yarborough, WH1
Grant, KA; Woolverton, WL1

Reviews

10 review(s) available for acamprosate and Chemical Dependence

ArticleYear
Study characteristics influence the efficacy of substance abuse treatments: A meta-analysis of medications for alcohol use disorder.
    Drug and alcohol dependence, 2018, Sep-01, Volume: 190

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Female; Humans; Male; Middle Aged; Naltrexone; Randomized Controlled Trials as Topic; Substance-Related Disorders; Taurine; Treatment Outcome

2018
Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders.
    Rhode Island medical journal (2013), 2014, Oct-01, Volume: 97, Issue:10

    Topics: Acamprosate; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Directive Counseling; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Practice Patterns, Physicians'; Substance-Related Disorders; Taurine; United States

2014
The implications of medication development in the treatment of substance use disorders in developing countries.
    Current opinion in psychiatry, 2009, Volume: 22, Issue:3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Comorbidity; Developing Countries; Disulfiram; HIV Infections; Humans; Methadone; Narcotic Antagonists; Prevalence; Public Policy; Substance Abuse, Intravenous; Substance-Related Disorders; Taurine

2009
Addiction treatment: level of care determination.
    Primary care, 2011, Volume: 38, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Behavior Therapy; Cognitive Behavioral Therapy; Health Status Indicators; Humans; Inpatients; Mass Screening; Naltrexone; Narcotic Antagonists; Outpatients; Primary Health Care; Substance-Related Disorders; Taurine

2011
Research advances in the understanding and treatment of addiction.
    The American journal on addictions, 2003, Volume: 12, Issue:s2

    Topics: Acamprosate; Alcohol Deterrents; Brain; Chronic Disease; Disease Progression; Humans; Naltrexone; Narcotics; Prognosis; Recurrence; Risk Factors; Substance-Related Disorders; Taurine

2003
Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms.
    Neurotoxicity research, 2006, Volume: 10, Issue:3-4

    Topics: Acamprosate; Alcohol Deterrents; Animals; Antipsychotic Agents; Clozapine; Diagnostic Imaging; Glutamates; Humans; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Substance-Related Disorders; Taurine

2006
Substance abuse and schizophrenia: pharmacotherapeutic intervention.
    Journal of substance abuse treatment, 2008, Volume: 34, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Antipsychotic Agents; Clozapine; Disulfiram; Drug Interactions; Humans; Naltrexone; Narcotics; Schizophrenia; Substance-Related Disorders; Taurine

2008
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2008, Volume: 9, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Biological Psychiatry; Carbamazepine; Disulfiram; Fructose; Health Planning Guidelines; Humans; Naltrexone; Ondansetron; Societies, Scientific; Substance-Related Disorders; Taurine; Topiramate

2008
Recent developments in the pharmacotherapy of alcohol dependence.
    Journal of consulting and clinical psychology, 1996, Volume: 64, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Anti-Anxiety Agents; Buspirone; Disulfiram; Ethanol; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Substance-Related Disorders; Taurine

1996
Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings.
    Journal of substance abuse treatment, 1999, Volume: 16, Issue:2

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Bupropion; Forecasting; Humans; Methadyl Acetate; Naltrexone; Substance-Related Disorders; Taurine; Tobacco Use Disorder

1999

Trials

1 trial(s) available for acamprosate and Chemical Dependence

ArticleYear
Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Journal of studies on alcohol and drugs, 2011, Volume: 72, Issue:1

    Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior Therapy; Family; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Placebos; Sex Characteristics; Substance-Related Disorders; Taurine; Treatment Outcome

2011

Other Studies

12 other study(ies) available for acamprosate and Chemical Dependence

ArticleYear
A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use.
    Substance abuse treatment, prevention, and policy, 2020, 01-13, Volume: 15, Issue:1

    Topics: Acamprosate; Addiction Medicine; Adult; Aged; Alcohol Deterrents; Alcoholism; Buprenorphine; Emergency Service, Hospital; Female; Gabapentin; Humans; Male; Middle Aged; Naltrexone; Ontario; Opioid-Related Disorders; Patient Acceptance of Health Care; Primary Health Care; Referral and Consultation; Socioeconomic Factors; Substance Abuse Treatment Centers; Substance-Related Disorders; Time Factors; Young Adult

2020
The Persistent Challenge of Developing Addiction Pharmacotherapies.
    Cold Spring Harbor perspectives in medicine, 2021, 11-01, Volume: 11, Issue:11

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Drug Therapy; Humans; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Smoking Cessation Agents; Substance-Related Disorders; Varenicline

2021
Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
    International journal of environmental research and public health, 2021, 08-23, Volume: 18, Issue:16

    Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Female; Humans; Middle Aged; Naltrexone; Substance-Related Disorders

2021
Access to Addiction Pharmacotherapy in Private Health Plans.
    Journal of substance abuse treatment, 2016, Volume: 66

    Topics: Acamprosate; Buprenorphine; Cost Sharing; Evidence-Based Practice; Formularies as Topic; Health Services Accessibility; Humans; Insurance, Health; Naltrexone; Substance-Related Disorders; Surveys and Questionnaires; Taurine; United States

2016
Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.
    Addictive behaviors, 2011, Volume: 36, Issue:6

    Topics: Acamprosate; Alcohol Deterrents; Buprenorphine; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Patient Education as Topic; Substance Abuse Treatment Centers; Substance-Related Disorders; Taurine; United States

2011
Pharmacotherapy for adolescent alcohol use disorder.
    CNS drugs, 2012, Jul-01, Volume: 26, Issue:7

    Topics: Acamprosate; Adolescent; Alcohol-Related Disorders; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Central Nervous System Stimulants; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Disulfiram; Humans; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders; Taurine

2012
Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice.
    Addictive behaviors, 2006, Volume: 31, Issue:11

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Australia; Bupropion; Dopamine Uptake Inhibitors; Female; Health Care Surveys; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Substance-Related Disorders; Taurine; Tobacco Use Disorder

2006
Schizophrenia and co-occurring substance use disorder.
    The American journal of psychiatry, 2007, Volume: 164, Issue:3

    Topics: Acamprosate; Adult; Alcohol-Related Disorders; Antipsychotic Agents; Comorbidity; Diagnosis, Dual (Psychiatry); Disulfiram; Humans; Ill-Housed Persons; Male; Naltrexone; Schizophrenia; Substance-Related Disorders; Taurine

2007
[Pharmacotherapy of alcoholism].
    Der Nervenarzt, 1996, Volume: 67, Issue:1 Suppl

    Topics: Acamprosate; Alcoholism; Female; Humans; Male; Substance-Related Disorders; Taurine

1996
Teaching the brain to take drugs.
    Science (New York, N.Y.), 1998, Jun-26, Volume: 280, Issue:5372

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Behavior, Addictive; Brain; Cocaine; Cocaine-Related Disorders; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Rats; Receptors, Glutamate; Substance-Related Disorders; Synaptic Transmission; Taurine

1998
Addiction medicine for the primary care physician.
    The Journal of the Oklahoma State Medical Association, 2001, Volume: 94, Issue:11

    Topics: Acamprosate; Alcohol Deterrents; Alcoholics Anonymous; Alcoholism; Antidepressive Agents, Tricyclic; Disulfiram; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Primary Health Care; Recurrence; Risk Factors; Severity of Illness Index; Substance-Related Disorders; Taurine; Treatment Outcome

2001
Reinforcing and discriminative stimulus effects of Ca-acetyl homotaurine in animals.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 32, Issue:3

    Topics: Acamprosate; Animals; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Self Administration; Substance-Related Disorders; Taurine

1989